Kouki Fuchino

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Purdue Pharma L.p., Shionogi Company Limited, Shionogi & Co., Ltd.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kouki Fuchino. Retrieved from https://idiyas.com/inventor/kouki-fuchino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

Shionogi Company Limited

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527775 - Heteroaromatic derivatives having serotonin receptor binding activity (2026-01-20),

2. 11111246 - Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds (2021-09-07),

3. 10519156 - 9'-Aza[3,9′-bi(bicyclo[3.3.1]nonan)]-3′-one and preparation thereof (2019-12-31),

4. 9758513 - Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity (2017-09-12),

5. 9540359 - Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity (2017-01-10),

6. 9527840 - Substituted-quinoxaline-type piperidine compounds and the uses thereof (2016-12-27),

7. 9278967 - Substituted-quinoxaline-type piperidine compounds and the uses thereof (2016-03-08),

8. 8846929 - Substituted-quinoxaline-type piperidine compounds and the uses thereof (2014-09-30),

Title: Kouki Fuchino: Innovator in Pharmaceutical Compounds

Introduction

Kouki Fuchino is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for pain management. With a total of seven patents to his name, Fuchino's work has the potential to impact medical treatments significantly.

Latest Patents

Fuchino's latest patents include innovative compounds such as Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds. This invention relates to compositions that comprise an effective amount of these compounds and methods to treat or prevent conditions like pain. Another notable patent is for 9'-Aza[3,9′-bi(bicyclo[3.3.1]nonan)]-3′-one and its preparation. This patent discloses compounds of specific formulas and their utility in manufacturing processes for obtaining these compounds, which also aim to treat or prevent pain.

Career Highlights

Throughout his career, Kouki Fuchino has worked with reputable companies in the pharmaceutical industry. Notable among these are Purdue Pharma L.P. and Shionogi & Company Limited. His work in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and therapeutic applications.

Collaborations

Fuchino has collaborated with several professionals in his field, including Naoki Tsuno and Jiangchao Yao. These collaborations have likely contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Kouki Fuchino stands out as a significant figure in pharmaceutical innovation, with a focus on compounds that address pain management. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.